Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Apr 04, 2024 8:57am
91 Views
Post# 35969942

RE:RE:RE:RE:RE:RE:RE:Listen up folks and listen WELL: As disclosed by the CEO of

RE:RE:RE:RE:RE:RE:RE:Listen up folks and listen WELL: As disclosed by the CEO of
QContinuum1 wrote: Make no mistake, I believe that LABS has substanstial potential and it's why I haven't sold out.  It's not a lie when I say that I have 1.5e6 shares and I bought that many because I believe this is horribly undervalued.

That said, there have been so many 'potential catalysts' over the years and none have moved LABS up.  Everything you say is totally correct, but a rec sector move shouldn't appreciably move LABS given the pivot to pharma (a pivot that caused some longer term pain but totally the right one).

By rights, LABS should already be triple from current levels so let's hope the next few quarterlies tell the tale.



I have a good chunck of change invested here and have not sold either but its time for them to start putting up........

i will give them another Q. the talk and promiss of endless posibilitys is wearing a little thin at some point you actually have to show that things are paying off ...
Pidduck said news is imminent a good sign ( depending on the deffinition of imminent) well mine is by Q1

its then i will re-evaluate the size of my position in MPL 

i will never not own MPL shares it just comes down to how many as there is good opertunitys and value in a few other sectors of the market
<< Previous
Bullboard Posts
Next >>